Search

everythinglearnresearchcommunity

for

Search:↓

Epidermal growth factor helps hair stem cells grow by activating specific cell pathways.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Drug repurposing shows promise for treating many medical conditions.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

ZD1839 can cause skin issues like acne and hair changes.

Lung cancer biology differs between women and men, with women responding better to certain treatments.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Promising cancer treatments were found, but the manufacturer closed.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

The platform effectively grows lung cancer cell spheroids for drug testing.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

A rare EGFR mutation in newborns leads to severe health issues and early death.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Noggin overexpression delays eyelid opening by affecting cell death and skin cell development.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

A blood pressure drug, diltiazem, may also help treat influenza.

Activating TRPV3 stops human hair growth.

Gamma-rays exposure during the resting phase of hair growth can damage hair regeneration and color in mice.